Zdrowie i gospodarka · 20/03/2012
FDA Seeks Public Comment on Proposed Postmarketing Adverse Drug Experience Reporting Requirements
The Food and Drug Administration (FDA) is seeking public comment on proposed postmarketing adverse drug experience reporting and recordkeeping requirements, as mandated by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →